Standing Together With Gratitude and Purpose
As we enter the New Year, we want to express our deep gratitude for your unwavering commitment to patients with Clostridioides difficile, an insidious disease that can strip people of their health, dignity, and independence. We are grateful to work alongside partners like you, who show up for these patients every day.
Policy Outlook: Building a microbiome-informed approach to agri-food systems and childhood nutrition policies
OpenBiome Foundation Launches to Catalyze Breakthroughs in Microbiome Science
July 16, 2025 (Woburn, MA) —Today, the pioneering nonprofit OpenBiome, becomes the OpenBiome Foundation – a bold evolution designed to fuel innovation, and ensure microbiome science delivers real impact for people all over the world. The shift reflects a changing regulatory environment while expanding on early successes and expertise.
Letter from the CEO: The Road Ahead as the OpenBiome Foundation
Today, we are proud to share the next chapter of our journey: OpenBiome is becoming the OpenBiome Foundation. With this transition, we renew and refocus our commitment to accelerating microbiome science and ensuring its benefits reach those who need them most.
Science in the Field: Dr. Walter Sandoval’s Mission to Map Rural Microbiomes in Paraguay
What motivated you to study the microbiome in rural Paraguay?
Only recently were we able to decipher the Paraguayan gut microbiome — and that research was limited to urban populations in the Asunción metro area. Until then, no other work had been done with a Paraguayan population, meaning Paraguay was vastly underrepresented in microbiome studies. Since microbiomes can vary significantly across populations, the next logical step in my goal to put Paraguay on the microbiome map was to begin studying rural communities.
Effectiveness and Safety of Fecal Microbiota Transplantation for Clostridioides Difficile Infection: Results From a 5344-Patient Cohort Study
Studies of the microbes living on and in our bodies are conducted mainly in a few rich countries, squandering opportunities to improve the health of people globally.
Advancing Care for Pediatric Patients with C. difficile: Insights from a Clinical Webinar on Investigational FMT
On March 28, 2023, OpenBiome convened a live webinar featuring a distinguished panel of physicians from Boston Children’s Hospital, Texas Children’s Hospital, and the University of Minnesota. The discussion focused on the clinical management of pediatric patients with Clostridioides difficile (C. difficile) infection, with a particular emphasis on diagnostic considerations and the use of investigational fecal microbiota transplantation (FMT).
OpenBiome, winner of the 2023 GBCHealth Futurist Award
OpenBIome CEO, Julie Barrett O’Brien, accepting the GBC Health Futurist award at during UNGA. The award recognizes “future seeking, innovating, ‘ahead of the curve’ companies that stand to change the future of global health.” “We are honored to accept this award,” said O’Brien, “and will use this platform to build a more equitable and inclusive system for microbiome scientists across the globe.”
Boosting microbiome science worldwide could save millions of children’s lives
Fecal microbiota transplantation for refractory immune-checkpoint-inhibitor colitis.
From Stool Donation to FMT Preparation: The Logistics of FMT Manufacturing
When is an FMT Treatment Ready for Use? Health Monitoring and Material Release
Tracking Patient Outcomes and Adverse Events: Considerations for Pharmacovigilance
Outcomes of Fecal Microbiota Transplantation in Patients With Inflammatory Bowel Diseases and Recurrent Clostridioides difficile Infection